Through this global alliance, PackGene, Weill Cornell Medicine, and GC4K, an Australian non-profit, intend to deliver a custom-tailored gene therapy solution to treat hereditary spastic paraplegia ...

Shining a Light on the Long Shadow of Subjectivity in Quality Risk Management ...

Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan ...

Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan ...

Shining a Light on the Long Shadow of Subjectivity in Quality Risk Management ...

Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan ...

Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan ...

Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan ...

Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan ...

Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan ...

Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan ...

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic ...